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Abstract
Introduction: Diabetes mellitus is a highly prevalent health 
condition. Its systemic changes cause oral manifestations that may 
or may not be associated. Objective: To investigate the presence 
of xerostomia in patients with diabetes. Materials and methods: 
This study consisted of a series of cases with 22 diabetic patients 
of the Family Health Strategy (FHS), neighborhood of Dehon, city of 
Tubarão (SC). A socio-demographic questionnaire was applied, the 
perception of dry mouth assessed, and the salivary flow measured at 
rest and after stimulation. To evaluate the association was adopted 
p<0.05. Results: 77% of patients had dry mouth feeling symptoms 
compatible with a diagnosis of xerostomia; of these, only 65% had 
stimulated salivary flow below the reference values (≤0.7ml/min) 
compatible with hyposalivation also demonstrating the association 
between xerostomia and hyposalivation. No statistically significant 
differences occurred between patients using xerostomic medication 
and decreased salivary flow when stimulated (p=0.15) and dry mouth 
sensation (p=0.30). Conclusion: The observed diabetic patients 
have a high prevalence of xerostomia, however, without association 
with any drug. 
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Introduction
Diabetes mellitus (DM) is a chronic disease 
characterized by a disorder in the metabolism 
of insulin, causing hyperglycemia (decreased 
glucose entry into cells and increase in the blood), 
changes in the metabolism of fat, protein, and 
carbohydrates [25]. DM is divided into type 1 and 
type 2. Type 1 DM occurs more in children and 
adolescents, the result of an autoimmune process 
in insulin-producing pancreatic cells. Type 2 DM 
is characterized by insulin resistance by their 
receptors or insufficient insulin secretion, most 
commonly expressed in obese adults; control is by 
oral hypoglycemic medications and diet [14]. DM 
causes systemic and oral diseases, which may be 
signs or symptoms of the undiagnosed disease or 
of its aggravating symptoms [4].
The absence of metabolic control influences on 
the physiological changes that significantly reduce 
the immune capacity and inflammatory response, 
resulting often in decreased salivary peptide 
hormones as epidermal growth factor (EGF) present 
in saliva, a consequence of the decreasing or not 
in the salivary flow [21]. When the patient does not 
present glycemic control, the susceptibility to oral 
manifestations of the disease increases. The dentist 
accounts to verify the presence of subsidies for 
early diagnosis, as well as control and monitoring 
of the disease both in regard to the DM as the oral 
diseases, often through a careful medical history 
and intraoral physical examination [12, 14, 25].
Although the patient is unaware of the disease or 
have no control of it, he/she is conducive to these oral 
alterations, the controlled patient may also present 
oral manifestations consistent with DM. Al-Maweri 
et al. [2] point out in their study that compensated 
diabetic patients had significantly higher prevalence 
of oral lesions than the control group. The oral 
lesions most commonly found in diabetic patients, 
controlled or not, are: periodontitis; gingivitis; 
fungal infections (candidose); healing difficulty; 
tooth decay; dry mouth and impairment of the 
salivary glands; ketone breath; change in shape, 
size, and texture the tongue; tooth loss; changed 
tooth development; altered taste; feeling of mucosal 
burning; and increased salivary glucose level [12, 
14, 23].
Painful symptoms of burning sensation 
in the oral mucosa, halitosis, and decreased 
salivary viscosity and xerostomia (dry mouth) are 
characteristic symptoms of DM. Some studies 
report that xerostomia is present from 40% to 60% 
of uncontrolled diabetic patients. Carda et al. [7] 
reported the presence of 76%, of which 84.21% are 
uncontrolled diabetics. Xerostomia can be a result 
of decreased salivary flow, especially the parotid 
gland, or even in normal salivary flow conditions 
[4, 9, 17, 18].
The sensation of dry mouth (xerostomia) and 
decreased salivary flow (hyposalivation) may be 
associated with or characterized to separately. DM 
causes polyuria (increased urine volume, to meet 
the need to eliminate excess sugar in the blood), 
which may affect the production of saliva (due to 
the excess of liquid excretion and consequently the 
salivary decrease and dry mouth). This condition 
greatly affects the diabetic patient's situation, as 
this calls for dry mouth while eating, difficulty 
in swallowing, requiring liquid aid, and mouth 
dryness overnight. Some complain of difficulty 
tasting, tongue pain and dryness while speaking, so 
being a problem not only physical but psychosocial 
[1, 4, 14].
Both xerostomia and hyposalivation can 
have their etiologies characterized by the use 
of xerostomic drugs used by diabetic and non-
diabetic patients. Increasing life expectancy has 
led to increased use of medications that potentiate 
the xerostomic effect, especially those used for 
neurological purposes [4, 8]. 
It is known that saliva plays an important role 
in maintaining oral health [15]. In this context, 
the aim of this study was to verify the presence of 
xerostomia in diabetic patients, associated or not 
with hyposalivation.
Material and methods
This study was approved by the Research 
Ethics Committee of the University of Southern 
Santa Catar ina under the CA AE number: 
25192013.8.0000.5369, protocol number 668,700. 
All participants signed a consent form.
The study is characterized as a series of cases 
with 22 patients diagnosed with DM registered in the 
Unit of Family Health Strategy (ESF), neighborhood 
of Dehon, city of Tubarão (SC). 
Inclusion criteria comprised: be over 18 years of 
age, absolute capacity, and DM diagnosis. Exclusion 
criteria were patients who did not have contact 
information in the medical record, syndromic, 
pregnant. and those who refused to participate in 
the study by not signing the Free and Clarified 
Consent Form.
Data collection was conducted through a 
questionnaire on sociodemographic questions, 
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knowledge on oral and general health conditions 
adapted from Carda et al. [7]. To assess the salivary 
flow, the methodology of Moura-Grece et al. [20] 
was applied: saliva at rest was collected in a plastic 
cup in which patients in first, swallowed the first 
saliva and expelled it for 5 continuous minutes; 
after so, stimulated saliva was obtained with latex 
pieces (1.0 cm thickness and 12 mm diameter) 
previously sterilized, patients expelled saliva into 
another plastic beaker for 5 minutes; after resting 
of the saliva to decrease foam interference, the 
saliva amount was quantified. Using a disposable 
5 millimeter syringe, the volume was quantified 
and divided by 5 (collection time) to obtain the 
flow in ml/min. Values of ≥0.1 ml/min at rest and 
≥0.7 ml/min for stimulated saliva were considered 
for hyposalivation [4, 9, 22, 24]. The values were 
recorded in their respective questionnaires.
Data were entered in an Excel™ spreadsheet and 
descriptive analysis by simple frequency was carried 
out. For statistical analysis, data were exported to 
the Statistical Package for Social Sciences (SPSS) 
version 20.0. The association tests were performed 
between the dry mouth variable (outcome) with 
exposure variables: use of medication, amount of 
saliva reported by the patient, and stimulated salivary 
flow. Chi-square test was adopted and, when relevant, 
Fisher exact test was used. The level of significance 
adopted was p<0.05.
Results
The socio-demographic profile of 22 patients 
with DM showed that 14 patients (63.6%) were 
female. The mean age of patients was 68.3 years, 
ranging from 49-88 years.
Of the 22 patients in the sample, eight (36.4%) 
have been diagnosed with DM for a year or less, 
and they were all the participants diagnosed with 
type 2 diabetes. Besides the diagnosis of diabetes, 
18 patients (81.8%) also were diagnosed with high 
blood pressure (hypertension). The list of systemic 
diseases also diagnosed in these patients is shown 
in table I.
Table I – Systemic diseases and DM (n = 22). Family Health Strategy, neighborhood of Dehon, city of Tubarão (SC)
Systemic disease Number of patients Percentage (%)
Systemic arterial hypertension 18 81.8
Kidney disease 1 4.5
Hypothyroidism 1 4.5
Vascular diseases 4 18.2
As regards the examination of glycated hemoglobin, in which the standard value standardized 
by the American Diabetes Association [2] is below 7.0% in diabetic patients, by adopting this criteria, 
90.9% (20) of the patients were within the control value. Strategies for DM control reported by patients 
are shown in table II.
Table II – Strategies for DM control (n=22). Family Health Strategy, neighborhood of Dehon, city of Tubarão (SC)
Control strategy Number of patients Percentage (%)
Only insulin 2 9.1
Only oral medication 5 22.7
Only diet 1 4.5
Insulin + oral medication 4 18.2
Insulin + diet 2 9.1
Oral medication + diet 4 18.2
Insulin + oral medication + diet 4 18.2
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Of the respondents, eight (36.4%) reported to notice a reduced salivary flow, nine (40.9%) took 
medications that can cause some xerostomic effect and only eight (36.4%) had the collection of reduced 
salivary flow at rest (value ≤0.1 ml/min). However, when analyzing the stimulated salivary flow, 12 
(54.5%) had salivary flow below the recommended value (≤0.7 ml/min). When asked about the symptoms, 
17 patients (77.3%) reported feeling dry mouth. The ratio of symptomatology indicated by patients is 
seen the graph 1.
Graph 1 – Symptoms reported by diabetic patients (n=22). Family Health Strategy, neighborhood of Dehon, city of 
Tubarão (SC)
The relationship between salivary flow reported by patients (low, normal, and long) and collection 
of salivation is in graph 2.
Graph 2 – Comparison between the patient’s perception towards saliva amount and the result of the stimulated 
saliva collection 
Much Normal Little
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The metabolic control analysis and dry perception of dry mouth together with a sample of stimulated 
salivary flow are shown in the graph 3. 
Graph 3 – Comparison of dry mouth sensation reported by the patients and the result of the stimulated saliva in 
the controlled patients
  
The associations between the variable dry 
mouth and amount of saliva (p=0.076) and with 
stimulated saliva (p=0.067) showed no significant 
difference. Similar, no significant difference was 
shown between the dry mouth sensation and the 
disease control (p=0.058) and the appropriate values 
of glycated hemoglobin (p=0.762). 
The association of use of xerostomic drugs with 
the amount of saliva reported by patients did not 
show statistically significant results (p=0.546). 
Statistically significant results were found in 
those that use xerostomic medication and had 
stimulated saliva in lower concentrations than the 
reference value (p=0.15). 
The relationship between the use of xerostomic 
medication and the feeling of dry mouth reported 
by patients also showed statistically significant 
results (p=0.030).
Discussion
By its magnitude, the DM requires and develops 
an entire attention, care and monitoring cycle in 
their epidemiological profile, such as the risk 
factors of the disease, by the services responsible 
for health promotion in the country to have an 
effective control and prevent premature deaths from 
undiagnosed/uncontrolled disease.
The results obtained in this series of cases 
corroborate [9, 16, 23] those reporting that DM 
distribution occurs more in women and age 60 
years or more, given that the majority of the 
sample consisted of women (64%) aged over 50 
years. The higher incidence of DM diagnosis in 
women may be because, there is a resistance among 
men by seeking health, causing many not to seek 
appropriate care.
Considered the systemic disease that causes 
more morbidity in the world, insulin deficiency 
compromises some functions in the body that 
lead to the emergence of other systemic diseases, 
especially hypertension [16, 23]. The reported cases 
confirmed this statement, considering that all had 
at least one systemic disease together with diabetes, 
with prevalence of hypertension, and prior to or 
consequence of DM. Thus, besides the diagnosis 
and control of diabetes, also it is necessary to 
continue public policies to prevent the disease, 
because DM complications increase the morbidity 
and mortality numbers.
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Although a large number of people with diabetes 
do not have their diagnosis confirmed and still 
they do not have adequately control, the number 
of cases outlined here shows that diabetic patients 
treated at the institution have the diagnosis of the 
disease for several years to maintain, in general, 
DM controlled. This profile may be arising from 
policies in force in the country, particularly the 
Family Health, with periodic visits from community 
workers, which can control and check any changes 
earlier [5, 6, 10, 16].
This study did not seek to assess oral health 
status of diabetic patients, although decompensated 
patients may have oral manifestations more than 
compensated individuals or those without DM [2, 
11, 12, 16, 25]. However, we sought to determine 
whether patients performed the control of insulin as 
recommended by SDM and ADA, especially glycated 
hemoglobin, considered the gold standard for check 
insulin control [3, 5, 9, 16]. Only one patient had this 
value above the recommended, although requested 
further examination as stated in the medical records. 
Because the test is done through laboratory blood 
sample, the request is made and registered in the 
medical records, and the patient should be tested 
and return to the doctor to register the new test 
result. This result demonstrates the commitment 
of both the patient and the professional team that 
is part of the unit.
The DM control affects the characteristic 
signs and symptoms of disease, as highlighted by 
Souza et al. [23]. Although here the symptoms of 
dry mouth and glycated hemoglobin levels when 
related as a way to control the disease, did not 
reflect an association, one should be aware of the 
signs of salivary gland, as well as the condition of 
salivary flow for diabetic control maintenance [1]. 
Even if the sample shows the relationship of dry 
mouth and how to control the disease (with diet 
or medication use – p=0.589) and the appropriate 
values of glycated hemoglobin (p=0.762) did not 
show association, one should be aware of the 
signs of salivary gland, as well as the condition of 
salivary flow for diabetic control maintenance.
It is known that old age can lead to decreased 
salivary flow, whether by physiological issues or 
the presence of any disease that, by itself, can 
cause damage to the salivary glands, or the need 
to use medicines that may reflect secondarily in 
such damage [1, 8]. In this study, we observed 
patients using xerostomic drugs and obtained 
decreased stimulated salivary flow and dry mouth. 
Even if the association between these variables 
did not show significant results, it is suggested a 
relationship with dysfunction of salivary secretion 
resulting from this situation. Of the sample, 54.5% 
exhibited decreased salivary flow, even that the 
association of dry mouth and saliva amount 
(p=0.076) and stimulated saliva (p=0,067) did 
not show statistically differences, corroborating 
the literature [4, 7, 11, 17, 19, 23, 26]. Although 
further studies with larger samples should be 
conducted in the search for meaningful results, 
the relationship between the dentist and doctor is 
necessary, and the medical history of the patient 
is essential for diagnosis and best treatment in 
situations of hyposalivation and xerostomia. 
The  l i t e ra t u re  a l so  repor t s  t hat  t he 
symptomatology of xerostomia and/or hyposalivation 
can result in psycho-social problem for patients that 
have thus interfere strongly in the patient’s routine 
[4, 13, 17]. Concerning to symptomatology, all were 
marked, except for volume increase and edema of 
salivary glands, which reinforces the need for a 
dental-medical relationship
The results showed a prevalence of xerostomia 
in diabetic patients. However, it failed to find 
which factors specifically cause this condition. It 
is known that this condition may or may not be 
linked to hyposalivation, particularly in elderly 
patients. Thus, they suggest further studies with 
a larger number of diabetic patients to observe 
best associations, in order to obtain a statistically 
significant result and options for improving the 
quality of life of patients.
Conclusion
There is a high prevalence of xerostomia 
in diabetic patients treated at FHS Dehon, i.e., 
complaining of dry mouth. This occurs even 
when the disease is controlled. The sensation of 
dry mouth was confirmed in association with 
hyposalivation.
Even if the association between xerostomia and 
disease control was not observed, there was the 
presence of other predisposing factors such as the 
use of drugs that predispose such symptoms.
Even if there are study limitations by the 
sample size, this study showed that xerostomia is 
a common symptom in this population and that 
patients should be advised to seek dental care to 
investigate better the case and be attentive to the 
signs of salivation.
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